Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode | Biochemistry
![Pharmaceuticals | Free Full-Text | Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies Pharmaceuticals | Free Full-Text | Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00316/article_deploy/html/images/pharmaceuticals-15-00316-g001.png)
Pharmaceuticals | Free Full-Text | Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease | ACS Catalysis
Critical Review on Sustainability in Denim: A Step toward Sustainable Production and Consumption of Denim | ACS Omega
![Viruses | Free Full-Text | Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis Viruses | Free Full-Text | Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis](https://pub.mdpi-res.com/viruses/viruses-15-00250/article_deploy/html/images/viruses-15-00250-g001.png?1674116435)
Viruses | Free Full-Text | Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease | Journal of Medicinal Chemistry
![Pharmaceuticals | Free Full-Text | Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer Pharmaceuticals | Free Full-Text | Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00169/article_deploy/html/images/pharmaceuticals-14-00169-g001a.png)